patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
EVRYSDI
Marketedupdated 2mo agoby Genentech Inc
Approvedcommunity read0 votes
all catalysts(16)
approval · 16
Aug 7, 2020
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Apr 30, 2021
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
May 27, 2022
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
May 27, 2022
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Sep 21, 2022
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Mar 24, 2023
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Oct 3, 2023
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Feb 29, 2024
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Sep 17, 2024
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Feb 11, 2025
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Feb 11, 2025
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Jan 21, 2026
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Jan 21, 2026
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Jan 21, 2026
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Feb 10, 2026
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
Feb 10, 2026
approval
EVRYSDI (RISDIPLAM) — FDA approval
EVRYSDI
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that